Company intelligence / Profile preview

Daiichi Sankyo Healthcare

Chuo-ku, Tokyo, Japan

Ownership: Private
Employees: ~612
Development stage: Other

Overview

Daiichi Sankyo Healthcare is a leading Japanese company in the over-the-counter (OTC) and consumer health sector. A wholly-owned subsidiary of Daiichi Sankyo, it was formed in 2006 by merging the healthcare divisions of Daiichi Pharmaceutical and Sankyo. The company holds top market shares in Japan for pain relief, gastrointestinal treatments, and medicated skincare through household brands like Loxonin S and Transino.

Therapeutic areas: ImmunologyNeurologyDermatologyInfectious DiseasesPulmonologyGastroenterology
Modalities: Small moleculePeptidesTopical formulation
Industry: Pharma

Drug pipeline

2 assets

Makiron

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

Takeda Consumer HealthcareMitsubishi Tanabe Pharma

Beyond the preview

Go deeper on Daiichi Sankyo Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daiichi Sankyo Healthcare.

Explore the full profile